Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Currently the standard practice in tumor biomarker research still relies on invasive tumor biopsy from local sites followed by molecular testing or NGS assay. However, this only provides a very limited characterization of tumor composition. Recent studies in non-invasive biomarker research have demonstrated the potential advantages of using cell-free nucleic acids isolated from blood plasma to study genetic heterogeneity of tumor population and dissect the complex cancer clonal architecture. Overall, this study demonstrates that Oncomine™ Pan-Cancer Cell-Free Assay provides a unique and complete NGS solution for comprehensive genetic mutation assessment using in vitro and in vivo liquid biopsy models.
Please fill out the form below to download this poster.